Evidence map›Paper›PMID 41473545›Full record

ArticleERJ open research2025

Treatment choice in mild to moderate sleep apnoea in the European Sleep Apnea Database.

Benedikt Fridriksson, Jan Hedner, Ding Zou, Johan Verbraecken, Sophia Schiza, Ozen K Basoglu, Dries Testelmans, Pavol Joppa, Zoran Dogas, Stefan Mihaicuta and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ERJ open research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Benedikt FridrikssonSleep Disorders Centre, Respiratory Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.ORCID https://orcid.org/0000-0003-2848-9381
Jan HednerSleep Disorders Centre, Respiratory Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
Ding ZouCentre for Sleep and Wake Disorders, Institute of Medicine, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden.ORCID https://orcid.org/0000-0003-2057-8558
Johan VerbraeckenDepartment of Pulmonary Medicine and Multidisciplinary Sleep Disorders Centre, Antwerp University Hospital and University of Antwerp, Antwerp, Belgium.ORCID https://orcid.org/0000-0002-6087-678X
Sophia SchizaSleep Disorders Unit, Department of Respiratory Medicine, School of Medicine, University of Crete, Heraklion, Greece.
Ozen K BasogluDepartment of Respiratory Medicine, Ege University Faculty of Medicine, Izmir, Türkiye.ORCID https://orcid.org/0000-0001-8168-6611
Dries TestelmansDepartment of Respiratory Diseases, University Hospitals Leuven, Leuven, Belgium.ORCID https://orcid.org/0000-0001-7303-9799
Pavol JoppaDepartment of Respiratory Medicine and Tuberculosis, Faculty of Medicine, P.J. Safarik University and L. Pasteur University Hospital, Kosice, Slovakia.ORCID https://orcid.org/0000-0001-5055-0682
Zoran DogasDepartment of Neuroscience and Sleep Medicine Center, University of Split School of Medicine, Split Croatia.
Stefan MihaicutaCenter for Research and Innovation in Precision Medicine of Respiratory Diseases, Department of Pulmonology, Timisoara, Romania.ORCID https://orcid.org/0000-0001-8897-8342
Tarja SaaresrantaDivision of Medicine, Department of Pulmonary Diseases, Turku University Hospital, University of Turku, Turku, Finland.
Ondrej LudkaDepartment of Internal Medicine, Geriatrics and Practical Medicine, University Hospital Brno, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Marta DrummondSleep and Non-Invasive Ventilation Unit, Hospital São João, Medicine Faculty of Porto University, Porto, Portugal.
Sebastien BaillyDivision of Medicine, Department of Pulmonary Diseases, Turku University Hospital, University of Turku, Turku, Finland.ORCID https://orcid.org/0000-0002-2179-4650
Ludger GroteSleep Disorders Centre, Respiratory Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.ORCID https://orcid.org/0000-0002-7405-1682
ESADA study group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: In mild to moderate obstructive sleep apnoea (OSA), positive airway pressure (PAP) and mandibular advancement devices (MADs) are recommended treatments according to guidelines. This cross-sectional study aimed to determine the clinical and organisational predictors for treatment recommendations in mild to moderate OSA. Methods: In the European Sleep Apnea Database, factors predicting the choice of MAD or PAP treatment were determined in patients with newly diagnosed mild to moderate OSA. Accessibility and reimbursement of MADs study sites was obtained Results: 6618 (65.5%) patients received PAP and 3491 (34.5%) were recommended MADs. MAD recommendations varied between centres (0% to 76%). Significant factors favouring MADs include mild Conclusion: In mild to moderate OSA, MADs are less frequently recommended than PAP, particularly amongst patients with a higher disease burden. MADs were more frequently used when they were more accessible and reimbursed. Thus, MADs are likely an underused treatment in mild to moderate OSA.

Identifiers

PMID41473545
PMCPMC12746115

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.